Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2397948 | 1.00 | ALDH1A1 (0.36) | ALDH1A1MAPK1NR3C1PGRCXCR2 | |
| SCHEMBL2399535 | 0.75 | ALOX5 (0.42) | ALDH1A1MAPK1NR3C1ALOX5SLC6A2 | |
| SCHEMBL2399533 | 0.75 | ALOX5 (0.42) | ALDH1A1MAPK1NR3C1ALOX5SLC6A2 | |
| SCHEMBL1272882 | 0.74 | IDO1 (0.34) | CXCR2CXCR1 | |
| SCHEMBL12800457 | 0.74 | IDO1 (0.34) | CXCR2CXCR1 | |
| SCHEMBL2100565 | 0.74 | IDO1 (0.34) | CXCR2CXCR1 | |
| SCHEMBL1272889 | 0.71 | POLB (0.36) | CXCR2CXCR1 | |
| SCHEMBL11699965 | 0.70 | CXCR2 (0.44) | ALDH1A1MAPK1CXCR2CXCR1LMNA | |
| SCHEMBL2396614 | 0.68 | CTSL (0.42) | ALDH1A1NR3C1LMNAGAA | |
| SCHEMBL2396618 | 0.68 | CTSL (0.42) | ALDH1A1NR3C1LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8013186-B2 | Haloalkyl containing compounds as cysteine protease inhibitors | VIROBAY, INC. (US) | 2011-09-06 | — | — | US | disclosed |
| US-20090023781-A1 | Haloalkyl Containing Compounds as Cysteine Protease Inhibitors | VIROBAY, INC. (US) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023781-A1 | Haloalkyl Containing Compounds as Cysteine Protease Inhibitors | CTSF, CTSS, CTSE | ALDH1A1 1944/4885MAPK1 4492/4885NR3C1 4864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.